Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Delayed hypersensitivity in man after booster anthrax vaccination]

E Shlyakhov1, E Rubinstein

  • 1Unité des Maladies Infectieuses, Chaim Sheba Medical Center, Tel-Hashomer, Israël.

Medecine Tropicale : Revue Du Corps De Sante Colonial
|January 1, 1996
PubMed
Summary

This study confirms the necessity of anthrax vaccine boosters by observing skin reactions post-vaccination. Booster responses were comparable to primary vaccination, indicating no adverse sensitization.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detectability of a self-illuminating lifeline for self-escape in smoke conditions of an underground mine.

Lighting research & technology (London, England : 2001)·2024
Same author

Assessing anti-estrogenic effects of AHR ligands in primary human and rat endometrial epithelial cells.

Reproductive toxicology (Elmsford, N.Y.)·2020
Same author

Primary endometrial 3D co-cultures: A comparison between human and rat endometrium.

The Journal of steroid biochemistry and molecular biology·2019
Same author

GH3 and RC-4BC cell lines are not suitable as in vitro models to study prolactin modulation and AHR responsiveness in rat pituitary.

Molecular and cellular endocrinology·2019
Same author

JUNO, the receptor of sperm IZUMO1, is expressed by the human oocyte and is essential for human fertilisation.

Human reproduction (Oxford, England)·2018
Same author

Nice Restrictiveness Compared To the Market Authorization.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Anthrax vaccination is critical for preventing Bacillus anthracis infection.
  • Understanding post-vaccination immune response dynamics is essential for optimizing vaccine efficacy.
  • Previous studies have indicated waning immunity over time, necessitating booster evaluation.

Purpose of the Study:

  • To determine the need for booster doses of the STI anthrax vaccine.
  • To assess the immune response dynamics following anthrax vaccine boosters.
  • To evaluate potential sensitization from anthraxine testing.

Main Methods:

  • A cohort study involving 138 subjects (subcutaneous) and 128 subjects (aerosol) vaccinated 15-24 months prior.
  • Administration of anthrax vaccine boosters via the same route as primary vaccination.

Related Experiment Videos

  • Intradermal anthraxine testing at multiple time points (D2-D365) post-booster to assess skin reactions.

    • Main Results:

    • Pre-booster positive skin reactions were observed in 14.3% (subcutaneous) and 8.3% (aerosol) of subjects.
    • A rapid increase in positive skin reactions was noted immediately after booster administration.
    • Post-booster reaction proportions were statistically similar to those after primary vaccination, with no evidence of sensitization.

    Conclusions:

    • Scientific evidence supports the requirement for anthrax vaccine boosters to maintain immunity.
    • Anthraxine testing following booster vaccination did not reveal sensitization.
    • Further research is needed on optimal booster dosage, timing, and acellular vaccine efficacy.